Panobacumab, a fully human monoclonal antibody for ventilator associated pneumonia caused by Pseudomonas aeruginosa
M. Tamm, Q. Lu, A. Dugard, P. Eggimann, E. Mercier, E. Giamarellos, V. Gafner, H. Lazar, A. Perez, P. F. Laterre (Genf, Bern, Switzerland; Paris, Limoges, Tours, France; Athens, Greece; Brussels, Belgium)
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Disease area: Respiratory critical care, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tamm, Q. Lu, A. Dugard, P. Eggimann, E. Mercier, E. Giamarellos, V. Gafner, H. Lazar, A. Perez, P. F. Laterre (Genf, Bern, Switzerland; Paris, Limoges, Tours, France; Athens, Greece; Brussels, Belgium). Panobacumab, a fully human monoclonal antibody for ventilator associated pneumonia caused by Pseudomonas aeruginosa. Eur Respir J 2010; 36: Suppl. 54, 5577
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: